Northern Centre for Cancer Care
Newcastle upon Tyne NE7 7DN
2 studies enrolling now · 7 studies all time
What they study most
Advanced Solid Tumor, Breast Cancer, Castration-Resistant Prostate Cancer, Head and Neck Cancer, Lymphoma, Non-Hodgkin, Non Small Cell Lung Cancer, Non-small Cell Lung Cancer, Ovarian Cancer, Solid Tumor, Adult, Solid Tumors
Studies at this site
- A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC) — Recruiting now
- A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors — Recruiting now
- Study of INCB123667 in Subjects With Advanced Solid Tumors — Running, not enrolling
- PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
- PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors — Stopped early
- A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early
- Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy — Completed